
Phase 3 data show pembrolizumab beats chemotherapy, offering durable first-line control with fewer severe toxicities and chemo-free potential.
In the fifth episode of Coffee With Suzy, Suzanne Soliman, PharmD, BCMAS, sat down with Joanna Lewis, PharmD, MBA and Christina Madison, PharmD, FCCP, AAHIVP.
In the fifth episode of Coffee With Suzy, Suzanne Soliman, PharmD, BCMAS, sat down with Joanna Lewis, PharmD, MBA and Christina Madison, PharmD, FCCP, AAHIVP to discuss the ongoing challenges of burnout in the pharmacy and insights on mental health.






